Yvoire Y-Solution 540

Yvoire Y-Solution 540 is a cross-linked hyaluronic acid dermal filler by YVOIRE, developed for aesthetic corrections that call for projection the face can move with. Clinics, aesthetic physicians and dermatologists typically choose it for anti-ageing correction and facial projection support, where a balance of elasticity and cohesion matters more than static filling; the Y-Solution numbers are lift tiers rather than concentrations, and the 540 and the 720 share the same stated composition while differing in lift positioning. The product incorporates 20 mg/mL (2.0%) of cross-linked hyaluronic acid with 0.3% lidocaine, made by the S-HICE process, and is for professional use by qualified practitioners only. It comes as one 1 mL syringe with two Terumo thin-wall 27G needles enclosed; shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

• Balances elasticity and cohesion, which the manufacturer describes as giving the gel spring-like characteristics
• Delivers visible projection while adapting to the dynamics of facial expression
• Cross-linked hyaluronic acid at 20 mg/mL, a higher concentration than the 360 reference in the same range
• Built on the manufacturer's S-HICE cross-linking process
• Includes 0.3% lidocaine, intended to improve patient comfort during injection
• Supplied with two Terumo thin-wall 27G needles
• Supports anti-ageing aesthetic correction and facial balancing
• Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration

適応と専門的な使用

主な適応

• Anti-ageing aesthetic treatment
• Facial projection support
• Treatments requiring a balance of elasticity and cohesion

専門的な使用

Yvoire Y-Solution 540 is a sterile, single-use injectable medical device supplied for administration by qualified medical practitioners only. Each syringe is intended for a single patient in a single session; any residual product must be discarded and never retained for reuse. Administration requires an aseptic technique and practitioner competence in facial anatomy and in the management of vascular complications, including intravascular occlusion. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles. Patients must be screened for sensitivity to amide-type local anaesthetics before treatment because the formulation contains lidocaine.

施術部位

• Face

対象となる患者

Suitable for adult patients seeking correction of age-related volume loss or facial projection support, with suitability determined by the treating practitioner following clinical assessment. Selection should account for skin quality, degree of volume deficit and the mobility of the treated region, since this reference is formulated for areas subject to facial expression. Patients with a known hypersensitivity to hyaluronic acid preparations or to amide-type local anaesthetics such as lidocaine should not be treated.

作用の仕組み： Yvoire Y-Solution 540 ​

Allparaで注文する理由

Allparaは、正規品で検証済みの YVOIRE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問